INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2015

Gut microbiota trimethylamine (TMA) production potential was associated with symptomatic atherosclerosis in public metagenomic data sets.

The authors reviewed literature on gut microbiota-derived trimethylamine (TMA), a metabolite linked to atherosclerosis development, to demonstrate big data integration workflows. By translating elucidated microbial pathways for TMA production into genomic orthologs, public (meta-)genomic databases were mined and linked to metadata. Reviewing pathway abundance showed that TMA production potential is associated with symptomatic atherosclerosis and facilitated identification of previously uncharacterized TMA-producing bacteria.

Shows an association, not proof of cause and effect.

Study type
Narrative review and metagenomic database analysis
Who was studied
Public metagenomic datasets and corresponding metadata
What was measured
Trimethylamine (TMA) production pathways and association with atherosclerosis

THE PAPER

Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine.

Falony G, Vieira-Silva S, Raes J. Annu Rev Microbiol, 2015.

PubMed 26274026 ↗DOI 10.1146/annurev-micro-091014-104422 ↗

Heart & arteriesGut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.